example@example.com 000-111-222
  • About Us
  • News Room
  • Resources
  • Why Sri Lanka
  • Contact Us
  • Login
Remediumone
  • Home
  • Our Services
  • Our Expertise
  • Our Collaborators
  • South Asia Forum
  • Clinical Trials Unit
Remediumone
  • Home
  • Our Services
  • Our Expertise
  • Our Collaborators
  • South Asia Forum
  • Clinical Trials Unit

Resources

Resources ยป Desidustat in Anemia due to Non- Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)
Home » Desidustat in Anemia due to Non- Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)
DESI STUDY Publication
July 25, 2022

By: admin

Desidustat in Anemia due to Non- Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)

Desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is being developed to treat anemia in patients with chronic kidney disease (CKD) without dialysis
dependency.

RemediumOne (Pvt) Ltd.

No 41/10, Guildford Crescent,
Colombo 07, Sri Lanka

+94112665266

+94112665300

inquiries@remediumone.com

Quick Links

  • Home
  • About Us
  • Our Services
  • Our Expertise
  • Contact Us

Follow Us

Remediumone © 2023 All Rights Reserved.

Developed by Lankacom

Search